Related Experiment Video

Updated: Aug 6, 2026

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
11:22

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing

Published on: October 15, 2019

Characterisation of the Novel HLA-DQB1*06:563N Allele by Next Generation Sequencing

Julien Lion1, Myriam Dollerschell1, Ségolène Bartczak1

  • 1Department Histocompatibility, Amiens University Medical Centre, Amiens, France.

HLA
|July 21, 2026
PubMed
Abstract

None:

HLA-DQB1*06:563N differs from the HLA-DQB1*06:04:01:01 allele by one nucleotide at position 2232 in exon 2.

Keywords:
HLA‐DQB1*06:563NHLAnext‐generation sequencingnovel allele

More Related Videos

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation
08:07

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation

Published on: September 6, 2017

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
07:26

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment

Published on: July 18, 2017

Related Experiment Videos

Last Updated: Aug 6, 2026

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
11:22

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing

Published on: October 15, 2019

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation
08:07

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation

Published on: September 6, 2017

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
07:26

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment

Published on: July 18, 2017

Related Concept Videos

Next-generation Sequencing03:00

Next-generation Sequencing

The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features.
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...

Articles linked to this work by shared authors, journal, and citation graph.

Identification of the Full Genomic Sequence of the HLA-DRB1*13:370N Allele by Next Generation Sequencing.

HLA·2026

Characterisation of the Novel HLA-DRB1*13:376 Allele by Next Generation Sequencing.

HLA·2026

Long-Read Next-Generation Sequencing Technologies Can Address Some Limitations of Short-Read Technologies in HLA Typing.

International journal of immunogenetics·2026

Characterisation of the Novel HLA-C*03:741 Allele by Next Generation Sequencing.

HLA·2026

Characterisation of the Novel HLA-DQB1*03:03:37 Allele by Next Generation Sequencing.

HLA·2026

Characterisation of the Novel HLA-C*07:1226 Allele by Next Generation Sequencing.

HLA·2026

Characterisation of the Novel HLA-DQA1*01:205N Allele by Next Generation Sequencing and Oxford Nanopore Sequencing.

HLA·2026

Characterisation of the Novel HLA-DRB1*10:52 Allele by Next-Generation Sequencing and Oxford Nanopore Sequencing.

HLA·2026

Identification of the Rare HLA-DQB1*06:426 Allele by Third-Generation Sequencing.

HLA·2026

Confirmation of HLA-C*07:24:02 in a Brazilian Individual by Next-Generation Sequencing.

HLA·2026

Identification of the Novel HLA-A*68:346 Allele in a Brazilian Individual by Next-Generation Sequencing.

HLA·2026

Extended Characterisation of the Coding Sequence of the HLA-C*07:101 Allele by Third-Generation Sequencing.

HLA·2026

Uncommon Concurrent Retinal and Cerebral Metastasis in High-risk Neuroblastoma: Diagnostic Utility of 68Ga-DOTATATE PET/CT Despite Negative 18F-FDG PET/CT.

Clinical nuclear medicine·2026

Immunoglobulin Superfamily Protein BTNL9 Functions as a Non-Canonical Transcriptional Regulator to Suppress NSCLC Through Cell Cycle and p53 Pathways.

International journal of molecular sciences·2026

Identification of the Novel HLA-DRB1*04:01:26 Allele by Next-Generation Sequencing.

HLA·2026

The HLA-C*08:01:45 Allele, Identified by Next-Generation Sequencing in an Indian Individual.

HLA·2026

Identification of the Novel HLA-DRB1*11:01:49 Allele Using Next-Generation Sequencing in a Chinese Individual.

HLA·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us